Nachsorge beim diffusen grosszelligen B-Zell-Lymphom – Evidenz und Empfehlung

Praxis (Bern 1994). 2018 Jan;107(1):31-34. doi: 10.1024/1661-8157/a002861.
[Article in German]
No abstract available

Keywords: CT; Diffuse large b-cell lymphoma; Diffuses grosszelliges B-Zell-Lymphom; Labor; Lymphome diffus à grandes cellules B; Nachsorge; Spättoxizität; analyses de laboratoire; follow-up; laboratory analyses; late toxicity; suivi post-traitement; tomographie par ordinateur/imagerie; toxicité à long terme.

Publication types

  • Review

MeSH terms

  • Aftercare / methods*
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Evidence-Based Medicine / methods*
  • Follow-Up Studies
  • Humans
  • Immunotherapy / methods*
  • Lymphoma, Large B-Cell, Diffuse / diagnosis
  • Lymphoma, Large B-Cell, Diffuse / therapy*
  • Positron Emission Tomography Computed Tomography
  • Prednisone / therapeutic use
  • Prognosis
  • Rituximab
  • Survival Rate
  • Vincristine / therapeutic use

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • R-CHOP protocol
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone